Viewing Study NCT04163718


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2025-12-26 @ 4:00 AM
Study NCT ID: NCT04163718
Status: TERMINATED
Last Update Posted: 2023-03-24
First Post: 2019-11-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-11-12
Start Date Type: ACTUAL
Primary Completion Date: 2022-10-19
Primary Completion Date Type: ACTUAL
Completion Date: 2022-10-19
Completion Date Type: ACTUAL
First Submit Date: 2019-11-12
First Submit QC Date: None
Study First Post Date: 2019-11-15
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-02-23
Results First Submit QC Date: None
Results First Post Date: 2023-03-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-23
Last Update Post Date: 2023-03-24
Last Update Post Date Type: ACTUAL